CIK 0001299130
- Accelerated filer
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Sign in to watch- Ticker
- PACB
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161590339
- Phone
- +1 650-521-8000
- Business address
- 1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025
- Former names
- PACIFIC BIOSCIENCES OF CALIFORNIA INC, NANOFLUIDICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,056,921
- in 1 filing, $2.1M under 10b5-1 plans
Net −$2,056,921. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-24 | Phillips James Michael SVP, Research & Development | Sale | −2,760 | $3.05 | $8K | 249,220 |
| 2020-02-20 | Phillips James Michael SVP, Research & Development | Sale | −5,050 | $4.48 | $23K | 251,980 |
| 2020-02-18 | Phillips James Michael SVP, Research & Development | Grant or award | +20,000 | 257,030 | ||
| 2019-03-15 | Phillips James Michael SVP, Research & Development | Grant or award | +7,500 | 237,030 | ||
| 2019-02-19 | Phillips James Michael SVP, Research & Development | Sale | −7,231 | $7.17 | $52K | 229,530 |
| 2019-02-15 | Phillips James Michael SVP, Research & Development | Grant or award | +8,000 | 223,156 | ||
| 2019-02-15 | Phillips James Michael SVP, Research & Development | Grant or award | +13,605 | 236,761 | ||
| 2018-02-15 | Phillips James Michael SVP, Research & Development | Grant or award | +15,000 | 209,166 | ||
| 2018-02-15 | Phillips James Michael SVP, Research & Development | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2017-02-15 | Phillips James Michael SVP, Research & Development | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2016-10-28 | Phillips James Michael SVP, Research & Development | Exercise or conversion | +20,000 | $2.18 | $44K | 201,449 |
| 2016-10-28 | Phillips James Michael SVP, Research & Development | Sale | −20,000 | $8.44 | $169K | 181,449 |
| 2016-10-28 | Phillips James Michael SVP, Research & Development | Exercise or conversion · Stock Option (right to buy) | −20,000 | 77,500 | ||
| 2016-07-29 | Phillips James Michael SVP, Research & Development | Exercise or conversion | +17,500 | $1.96 | $34K | 198,949 |
| 2016-07-29 | Phillips James Michael SVP, Research & Development | Exercise or conversion | +2,500 | $2.18 | $5K | 201,449 |
| 2016-07-29 | Phillips James Michael SVP, Research & Development | Sale | −20,000 | $8.45 | $169K | 181,449 |
| 2016-07-29 | Phillips James Michael SVP, Research & Development | Exercise or conversion · Stock Option (right to buy) | −17,500 | 0 | ||
| 2016-07-29 | Phillips James Michael SVP, Research & Development | Exercise or conversion · Stock Option (right to buy) | −2,500 | 97,500 | ||
| 2016-04-25 | Phillips James Michael SVP, Research & Development | Exercise or conversion | +20,000 | $1.96 | $39K | 201,449 |
| 2016-04-25 | Phillips James Michael SVP, Research & Development | Sale | −20,000 | $10.29 | $206K | 181,449 |
Page 1 of 2 · 31 trades